Sangamo BioSciences Announces Presentation At The 35th Annual J.P. Morgan Healthcare Conference

RICHMOND, Calif., Jan. 4, 2017 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D, Sangamo's chief executive officer, will participate in the 35^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11^th at 4:30 p.m. Pacific Time in San Francisco, California.

To access the live webcast, please visit the Investor and Media section of the Sangamo website, www.sangamo.com. The presentation will be archived on the Sangamo website for two weeks after the event.

SOURCE Sangamo BioSciences, Inc.

Related Links

http://www.sangamo.com